Literature DB >> 20951192

Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy.

Mingxin Li1, Weixin Wang, Jun Xue, Yong Gu, Shanyan Lin.   

Abstract

AIM OF STUDY: Nowadays diabetic nephropathy (DN) has become a serious problem. Astragalus membranaceus is a traditional herb used for thousands of years in China and East Asia for kidney disease. In modern medicine, Astragalus shows significant renal protective effect in DN. We aimed to systematically review the randomized and semi-randomized control trials to ascertain its role in the treatment of DN.
MATERIALS AND METHODS: PUBMED, MEDLINE, Chinese journal full-test database (CJFD), Chinese biological and medical database were searched by computer and manual searching. Two assessors independently reviewed each trial. 25 studies comprising 21 RCTs and 4 CCTs were involved including 1804 patients (945 in treatment group and 859 in control group). RESULTS AND
CONCLUSIONS: Astragalus injection had more therapeutic effect in DN patients including renal protective effect (BUN, SCr, CCr and urine protein) and systemic state improvement (serum albumin level) compared with the control group. ETHNOPHARMACOLOGICAL RELEVANCE: This study investigates the effect of Astragalus in DN patients. It suggests that although of unknown bioactive ingredients and mechanism of renal protection, the role of Astragalus in the treatment of DN can be disclosed and of profound significance. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951192     DOI: 10.1016/j.jep.2010.10.012

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  46 in total

1.  Astragalus polysaccharide suppresses excessive collagen accumulation in a murine model of bleomycin-induced scleroderma.

Authors:  Zhen-Feng Hao; You-Ming Su; Jing-Yang Liu; Cong-Min Wang; Rong-Ya Yang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

3.  Astragaloside IV protects new born rats from anesthesia-induced apoptosis in the developing brain.

Authors:  Jian Sun; Xiao-Ling Chen; Jin-Yu Zheng; Jian-Wei Zhou; Zheng-Liang Ma
Journal:  Exp Ther Med       Date:  2016-07-13       Impact factor: 2.447

Review 4.  Meta-analysis of Huangqi injection for the adjunctive therapy of aplastic anemia.

Authors:  Changtai Zhu; Yulu Gao; Ting Jiang; Cao Hao; Zongshuai Gao; Yongning Sun
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 5.  Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy.

Authors:  Lei Zhang; Yin Li; Xin-Feng Guo; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2015-12-19       Impact factor: 1.978

6.  Effect of astragaloside IV on diabetic gastric mucosa in vivo and in vitro.

Authors:  Ningding Wang; Frederick Siu; Yongbin Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 7.  Chinese medicine for treating diabetic nephropathy.

Authors:  Bin Wang; Lan Lin; Qing Ni; Cheng-lian Su
Journal:  Chin J Integr Med       Date:  2013-03-26       Impact factor: 1.978

8.  Pharmacokinetics and hepatic uptake of gliquidone affected by Huangqi injection.

Authors:  Fan Zhang; Yuhui Wei; Yan Zhou; Dan Wang; Liting Zhou; Jianping Zhang; Xinan Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-10-02       Impact factor: 2.441

9.  Inhibition airway remodeling and transforming growth factor-β1/Smad signaling pathway by astragalus extract in asthmatic mice.

Authors:  Zheng-Hai Qu; Zhao-Chuan Yang; Lei Chen; Zhi-Dong Lv; Ming-Ji Yi; Ni Ran
Journal:  Int J Mol Med       Date:  2011-12-23       Impact factor: 4.101

Review 10.  Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.

Authors:  Shufei Fu; Junhua Zhang; Francesca Menniti-Ippolito; Xiumei Gao; Francesca Galeotti; Marco Massari; Limin Hu; Boli Zhang; Rita Ferrelli; Alice Fauci; Fabio Firenzuoli; Hongcai Shang; Ranieri Guerra; Roberto Raschetti
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.